Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Septerna, Inc.NASDAQ: SEPN
Short-term Investments · Q3 FY2026 · quarter ended Sep 2026
Short-term investments rises 101.8% from a year ago
Short-term investments stood at $311.48M at the end of Q3 FY2026, up 101.8% from a year earlier and up 8.3% from the prior quarter.
Context
- Short-term investments amounted to 50.3% of total assets at the end of Q3 FY2026, up 24.8 pp from a year earlier.
- Short-term investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps rising in the next quarterly balance sheet after a +101.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 270.37M USD
- Year-over-year change
- +139.8%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 270.37M | +139.8% |
| FY2024 | 2024-12-31 | 112.73M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Short-term Investments vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 short-term investments of $311.48M is the 4th highest of the 7 companies compared; the peer median is $236.76M.
- Its year-over-year change of +101.8% is the highest of 3, against a peer median of +78.6%.
- Short-term investments amounts to 50.3% of total assets for SEPN, versus a peer median of 50.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.07B | +67.3% | +115.3% | 75.1% | |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $786.44M | — | — | 64.9% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $319.9M | +89.8% | +153.8% | 63.9% |
SEPNSepterna, Inc. | Sep 2026 | $311.48M | +101.8% | — | 50.3% |
| Mar 2026 | $153.62M | — | — | 36.6% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SEPN) | $236.76M | +78.6% | +134.6% | 50.3% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.